Testing effectiveness (Phase 2)Study completedNCT00362570
What this trial is testing
Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma
Who this might be right for
Oligoastrocytoma, MixedAnaplastic Oligodendroglioma
Ohio State University Comprehensive Cancer Center 1